bioMérieux Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 4/6
bioMérieux has been growing earnings at an average annual rate of 6.3%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 7.8% per year. bioMérieux's return on equity is 10.3%, and it has net margins of 10.8%.
Anahtar bilgiler
6.3%
Kazanç büyüme oranı
6.4%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 21.6% |
Gelir büyüme oranı | 7.8% |
Özkaynak getirisi | 10.3% |
Net Marj | 10.8% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings
Mar 31There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings
Sep 15Recent updates
Is bioMérieux (EPA:BIM) Using Too Much Debt?
Nov 01Is There An Opportunity With bioMérieux S.A.'s (EPA:BIM) 31% Undervaluation?
Oct 14bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing
Sep 26bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?
Sep 08Return Trends At bioMérieux (EPA:BIM) Aren't Appealing
Aug 03bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
May 30Investors Met With Slowing Returns on Capital At bioMérieux (EPA:BIM)
Apr 18bioMérieux's (EPA:BIM) Conservative Accounting Might Explain Soft Earnings
Mar 31bioMérieux S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 17These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Mar 15bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
Jan 27bioMérieux (EPA:BIM) Has More To Do To Multiply In Value Going Forward
Jan 06A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 16These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Oct 23bioMérieux (EPA:BIM) Has Some Way To Go To Become A Multi-Bagger
Oct 05There May Be Reason For Hope In bioMérieux's (EPA:BIM) Disappointing Earnings
Sep 15Estimating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Jun 30Returns At bioMérieux (EPA:BIM) Appear To Be Weighed Down
Jun 09Is bioMérieux (EPA:BIM) Using Too Much Debt?
Mar 31The Return Trends At bioMérieux (EPA:BIM) Look Promising
Feb 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jan 27bioMérieux (EPA:BIM) Has A Pretty Healthy Balance Sheet
Dec 16bioMérieux (EPA:BIM) Ticks All The Boxes When It Comes To Earnings Growth
Oct 18Is bioMérieux (EPA:BIM) Using Too Much Debt?
Sep 14Investors Should Be Encouraged By bioMérieux's (EPA:BIM) Returns On Capital
Aug 11An Intrinsic Calculation For bioMérieux S.A. (EPA:BIM) Suggests It's 20% Undervalued
Jul 23Do bioMérieux's (EPA:BIM) Earnings Warrant Your Attention?
Jul 05bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
May 26Shareholders Would Enjoy A Repeat Of bioMérieux's (EPA:BIM) Recent Growth In Returns
May 11bioMérieux (EPA:BIM) Is Paying Out A Larger Dividend Than Last Year
Apr 23bioMérieux (EPA:BIM) Has Announced That It Will Be Increasing Its Dividend To €0.85
Apr 09bioMérieux's (EPA:BIM) Dividend Will Be Increased To €0.85
Mar 25Does bioMérieux (EPA:BIM) Have A Healthy Balance Sheet?
Mar 13I Ran A Stock Scan For Earnings Growth And bioMérieux (EPA:BIM) Passed With Ease
Feb 08Why We Like The Returns At bioMérieux (EPA:BIM)
Dec 21Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Dec 07Here's Why We Think bioMérieux (EPA:BIM) Is Well Worth Watching
Nov 07Is bioMérieux (EPA:BIM) A Risky Investment?
Oct 07Investors Shouldn't Overlook bioMérieux's (EPA:BIM) Impressive Returns On Capital
Sep 22Estimating The Fair Value Of bioMérieux S.A. (EPA:BIM)
Sep 07Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Aug 06There's Been No Shortage Of Growth Recently For bioMérieux's (EPA:BIM) Returns On Capital
Jun 15A Look At The Fair Value Of bioMérieux S.A. (EPA:BIM)
May 31Here's Why I Think bioMérieux (EPA:BIM) Might Deserve Your Attention Today
Apr 30bioMérieux (EPA:BIM) Could Easily Take On More Debt
Mar 28The Trend Of High Returns At bioMérieux (EPA:BIM) Has Us Very Interested
Mar 13Calculating The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Feb 25If You Had Bought bioMérieux (EPA:BIM) Shares Five Years Ago You'd Have Earned 237% Returns
Feb 09If You Like EPS Growth Then Check Out bioMérieux (EPA:BIM) Before It's Too Late
Jan 20Could The Market Be Wrong About bioMérieux S.A. (EPA:BIM) Given Its Attractive Financial Prospects?
Dec 30These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
Dec 17Gelir ve Gider Dağılımı
bioMérieux nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 3,807 | 411 | 1,055 | 474 |
31 Mar 24 | 3,741 | 384 | 1,038 | 467 |
31 Dec 23 | 3,675 | 358 | 1,021 | 460 |
30 Sep 23 | 3,688 | 372 | 1,019 | 463 |
30 Jun 23 | 3,701 | 386 | 1,017 | 466 |
31 Mar 23 | 3,645 | 419 | 986 | 456 |
31 Dec 22 | 3,589 | 452 | 955 | 447 |
30 Sep 22 | 3,525 | 502 | 916 | 429 |
30 Jun 22 | 3,460 | 552 | 877 | 412 |
31 Mar 22 | 3,418 | 577 | 846 | 399 |
31 Dec 21 | 3,376 | 601 | 816 | 386 |
30 Sep 21 | 3,296 | 555 | 801 | 381 |
30 Jun 21 | 3,216 | 509 | 786 | 377 |
31 Mar 21 | 3,167 | 457 | 788 | 388 |
31 Dec 20 | 3,118 | 404 | 789 | 399 |
30 Sep 20 | 2,997 | 355 | 784 | 399 |
30 Jun 20 | 2,876 | 305 | 778 | 398 |
31 Mar 20 | 2,775 | 289 | 764 | 386 |
31 Dec 19 | 2,675 | 273 | 750 | 374 |
30 Sep 19 | 2,601 | 268 | 721 | 362 |
30 Jun 19 | 2,527 | 263 | 693 | 350 |
31 Mar 19 | 2,474 | 260 | 668 | 338 |
31 Dec 18 | 2,421 | 257 | 643 | 327 |
30 Sep 18 | 2,372 | 264 | 626 | 320 |
30 Jun 18 | 2,323 | 271 | 609 | 312 |
31 Mar 18 | 2,306 | 255 | 607 | 308 |
31 Dec 17 | 2,288 | 238 | 604 | 304 |
30 Sep 17 | 2,262 | 216 | 604 | 300 |
30 Jun 17 | 2,237 | 195 | 604 | 295 |
31 Mar 17 | 2,170 | 187 | 587 | 283 |
31 Dec 16 | 2,103 | 179 | 570 | 272 |
30 Sep 16 | 2,068 | 158 | 555 | 260 |
30 Jun 16 | 2,032 | 137 | 540 | 249 |
31 Mar 16 | 1,998 | 124 | 534 | 244 |
31 Dec 15 | 1,965 | 111 | 529 | 239 |
30 Sep 15 | 1,908 | 127 | 510 | 230 |
30 Jun 15 | 1,851 | 144 | 492 | 222 |
31 Mar 15 | 1,775 | 140 | 472 | 214 |
31 Dec 14 | 1,698 | 135 | 453 | 206 |
30 Sep 14 | 1,656 | 135 | 437 | 201 |
30 Jun 14 | 1,614 | 135 | 422 | 196 |
31 Mar 14 | 1,601 | 150 | 413 | 191 |
31 Dec 13 | 1,588 | 164 | 405 | 186 |
Kaliteli Kazançlar: BIM has high quality earnings.
Büyüyen Kar Marjı: BIM's current net profit margins (10.8%) are higher than last year (10.4%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: BIM's earnings have grown by 6.3% per year over the past 5 years.
Büyüme Hızlandırma: BIM's earnings growth over the past year (6.6%) exceeds its 5-year average (6.3% per year).
Kazançlar vs. Sektör: BIM earnings growth over the past year (6.6%) did not outperform the Medical Equipment industry 12.7%.
Özkaynak Getirisi
Yüksek ROE: BIM's Return on Equity (10.3%) is considered low.